Pharmaceutical compound
Identifiers | |
---|---|
IUPAC name
| |
CAS Number | |
PubChem CID | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C20H21NO |
Molar mass | 291.394 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
|
Danitracen (WA 335) is an antidepressant compound developed in the 1970s. Danitracen acts by blocking central and peripheral 5-HT receptors: it potentiates testosterone-induced sexual behavior in rats and abolishes the 5-hydroxytryptophan (5-HTP) induced hypermotility in mice. In amphetamine-treated rats, administration of danitracen lowered whole brain serotonin and norepinephrine levels. Danitracen was investigated in clinical trials in depressed patients. At 3 mg/day, danitracen was equipotent to 150 mg/day amitriptyline.
See also
References
- Engelhardt G (November 1975). "". Arzneimittel-Forschung (in German). 25 (11): 1723–37. PMID 1049.
- "Danitracen". Inxight Drugs. National Center for Advancing Translational Sciences (NCATS).
- Castañer J, Chatterjee SS (1976). "Danitracen". Drugs of the Future. 1 (6)): 279. doi:10.1358/dof.1976.001.06.1002525.
- Maj J, Baran L, Sowińska H, Gancarczyk L (1976). "The action of compound WA-335 on the central nervous system". Archivum Immunologiae et Therapiae Experimentalis. 24 (2): 205–22. PMID 945051.
- Maj J, Sowińska H, Baran L (1976). "Influence of WA-335, a factor which blocks serotonin receptors, on neuroleptic-induced catalepsy". Archivum Immunologiae et Therapiae Experimentalis. 24 (2): 197–203. PMID 945050.
- Matussek N, Benkert O, Fidetzis K, Flach D, Hermann HU, Kaumeier S, et al. (1976). "". Arzneimittel-Forschung (in German). 26 (6): 1160–2. PMID 786311.
Attribution: some content on this page was copied from the public domain source https://drugs.ncats.io/drug/SD507F5T2W.
Monoamine reuptake inhibitors | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DATTooltip Dopamine transporter (DRIsTooltip Dopamine reuptake inhibitors) |
| ||||||||||||||
NETTooltip Norepinephrine transporter (NRIsTooltip Norepinephrine reuptake inhibitors) |
| ||||||||||||||
SERTTooltip Serotonin transporter (SRIsTooltip Serotonin reuptake inhibitors) |
| ||||||||||||||
VMATsTooltip Vesicular monoamine transporters | |||||||||||||||
Others |
| ||||||||||||||
See also: Receptor/signaling modulators • Monoamine releasing agents • Adrenergics • Dopaminergics • Serotonergics • Monoamine metabolism modulators • Monoamine neurotoxins |
Tetracyclics | |
---|---|
Classes | |
Antibiotics | |
Antidepressants (TeCAs) | |
Steroids |